DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

TL-895

Generic Name: TL-895

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Phase 1

Recruiting

Posted: 2022/03/15

Sponsor:Telios Pharma, Inc.

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

Phase 2

Recruiting

Posted: 2021/05/07

Sponsor:Kartos Therapeutics,...

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Phase 1

Active, not recruiting

Posted: 2020/12/16

Sponsor:Telios Pharma, Inc.

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Phase 2

Recruiting

Posted: 2020/12/07

Sponsor:Telios Pharma, Inc.

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Phase 1

Recruiting

Posted: 2020/11/23

Sponsor:Kartos Therapeutics,...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Global Clinical Trials for Myelodysplastic Syndrome Show Significant Industry Investment in 2025

3 months ago

A comprehensive review of global Myelodysplastic Syndrome clinical trials reveals extensive research activity across G7 and E7 countries, with major pharmaceutical companies leading development efforts.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy